Jump to main content

Recombinant Product Development

The team develops and characterizes new recombinant proteins, such as in the development of monoclonal antibodies for the treatment of inflammatory diseases, hereditary angioedema or lipid metabolism disorders.


Introduction to the department

RPD Upstream

Upstream Development

Jessica Klos

Downstream Development

Christopher Kiselmann

Formulation Lyo and Stability Development


Global Bioanalytical Sciences


Pilot Plant